A complete application in a minute
Tailored resume and cover letter, ready to send.
Sarah Cannon Research Institute (SCRI) is seeking a Clinical Research Coordinator for Blood Cancer and Bone Marrow Transplant trials. You will manage enrollment, regulatory compliance, data entry, and site operations to ensure high-quality trial conduct.
You will review study designs with physicians, protect patient rights, coordinate shipments, and monitor safety events while collaborating with monitors, investigators, and staff across multiple sites.
It's More Than a Career, It's a Mission.
Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.
People who live with cancer - those who work to prevent it, fight it, and survive it - are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting‑edge research, SCRI is redefining cancer care around the world.
As the Clinical Research Coordinator for Blood Cancer and Bone Marrow Transplant (BMT) research you are responsible for overall clinical operations of the facility's blood cancer research program including enrollment, regulatory, quality, and site operations.
Salary range $79,000 - $90,000
Sarah Cannon Research Institute (SCRI) is one of the world's leading oncology research organizations conducting community‑based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first‑in‑human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI's research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S.
That's why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well‑being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information reg